齐鲁在线网|英飞凡联合 Tremelimumab 一线治疗不可切除的肝细胞癌达到了前所未有的生存率,患者三( 三 )


阿斯利康的愿景是重新定义癌症治疗并在未来攻克癌症 。
关于阿斯利康
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.
阿斯利康是一家科学至上的全球性生物制药企业 , 专注于研发、生产及营销处方类药品 , 重点关注肿瘤、罕见病、心血管、肾脏及代谢、呼吸和免疫等疾病领域 。 总部位于英国剑桥的阿斯利康业务遍布100多个国家 , 创新药物惠及全球数百万患者 。